Furthermore, the consistency of findings across all available trials based on a common eligibility pathway, coupled with a significant dose–response relationship, provides compelling support, and a strength of evidence that is more persuasive than would be the finding of a positive effect in an isolated dedicated trial with a marginally significant result.
1
—
—